Theoretical interactions could occur with medications affecting blood clotting, immune function, or tissue growth
In TRIUMPH-3, retatrutide meaningfully reduced certain cardiovascular risk factors, with the highest dose delivering average reductions of 37.0% in triglycerides, 16.5% in non-HDL cholesterol, 9.3 mmHg in systolic blood pressure, 7.5 in (19.0 cm) in waist circumference, and 51.2% in high-sensitivity C-reactive protein (hsCRP)
GLP-1 DAILY SUPPORT BUNDLE Designed to complement GLP-1 lifestyle routines with essential hydration, fiber, and protein to support daily nutrition and wellness goals
It is generally thought to be safe, at least in healthy adults
Weight loss from GLP-1 therapy can reduce your body's thyroid hormone needs, so some patients require lower levothyroxine doses after 8 to 12 weeks
Interaction with zidovudine